Using machine learning to identify patients with cancer that would benefit from immunotherapy
A new study examines the development of two machine learning models to classify the immunophenotype of a cancer specimen.
Apr 16, 2024
0
0
Mary Ann Liebert Inc. was founded in 1980 by Mary Ann Liebert in New Rochelle, NY. The company publishes peer-reviewed journals, books and trade magazines in a variety of fields. A sample of journals, include Genetic Engineering & Biotechnology News, Human Gene Therapy and Women's Health. BioConferences International Inc. is a subsidiary of Mary Ann Liebert Inc. This company's focus is to organize symposiums and conferences in Biotechnology, Women's Health, Alternative Medicine, Law and more.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A new study examines the development of two machine learning models to classify the immunophenotype of a cancer specimen.
Apr 16, 2024
0
0
Two new review articles in AI in Precision Oncology explore the role of artificial intelligence (AI) in early cancer detection. A primer provides an overview of AI, and the second review examines the promising clinical applications ...
Apr 11, 2024
0
1
A new study describes a novel surgical technique used to treat Moebius syndrome, a rare congenital condition leading to the inability to smile, oral incompetence, and a significant impact on social engagement. The study is ...
Mar 27, 2024
0
0
A new study published in the journal Diabetes Technology & Therapeutics has evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes. Tirzepatide is approved for managing type 2 diabetes. It improves ...
Mar 25, 2024
0
1
A new study has shown that overall and cause-specific mortality rates in individuals in the U.S. with low-risk differentiated thyroid cancer (DTC) are low. The study is published in Thyroid.
Mar 21, 2024
0
0
A new meta-analysis published in OMICS: A Journal of Integrative Biology helps shed light on how changes in mitochondria-related gene expression may cause the cardiotoxicity associated with the cancer therapy trastuzumab.
Mar 18, 2024
0
0
Retear and failure to heal are significant post-operative complications in rotator cuff repair surgery despite the use of commercially available rotator cuff repair grafts. Advances in tissue engineering have demonstrated ...
Mar 18, 2024
0
0
Patients generally exhibit high levels of satisfaction with telemedicine consultations, according to a new study. The time interval between the consultation and the assessment was one factor found to influence patient satisfaction.
Mar 13, 2024
0
0
Recent clinical trials utilizing high doses of adeno-associated virus (AAV) vectors have highlighted a new challenge to AAV gene transfer—activation of the complement system. A new article in Human Gene Therapy describes ...
Feb 22, 2024
0
4
In a new study published in the journal AI in Precision Oncology, Nikhil Thaker, from Capital Health and Bayta Systems, and co-authors, evaluated the performance of various LLMs, including OpenAI's GPT-3.5-turbo, GPT-4, GPT-4-turbo, ...
Feb 8, 2024
0
0